Follow
Muhlis Cem Ar
Muhlis Cem Ar
Istanbul University - Cerrahpasa
Verified email at istanbul.edu.tr - Homepage
Title
Cited by
Cited by
Year
COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature
A Murt, AE Eskazan, U Yılmaz, T Ozkan, MC Ar
Journal of medical virology 93 (1), 43, 2021
652021
Extended half-life coagulation factors: a new era in the management of hemophilia patients
MC Ar, C Balkan, K Kavaklı
Turkish Journal of Hematology 36 (3), 141, 2019
422019
Methods for individualising factor VIII dosing in prophylaxis
MC Ar, I Vaide, E Berntorp, S Björkman
European Journal of Haematology 93, 16-20, 2014
412014
Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion
AE Eskazan, D Eyice, EA Kurt, T Elverdi, FF Yalniz, A Salihoglu, MC Ar, ...
Leukemia Research 38 (7), 781-787, 2014
402014
The impact of obesity and insulin resistance on iron and red blood cell parameters: a single center, cross-sectional study
E Altunoğlu, C Müderrisoğlu, F Erdenen, E Ülgen, MC Ar
392014
Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data …
S Ongoren, AE Eskazan, V Suzan, S Savci, I Erdogan Ozunal, S Berk, ...
Hematology 23 (4), 212-220, 2018
352018
First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate
AE Eskazan, M Ayer, B Kantarcioglu, D Arica, N Demirel, D Aydin, ...
British journal of haematology 167 (1), 139-141, 2014
302014
Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma
M Cem Ar, T Soysal, G Hatemi, A Salihoglu, H Yazici, B Ulku
Annals of hematology 84, 609-613, 2005
302005
Outcomes of chronic myeloid leukemia patients with early molecular response at 3 and 6 months: a comparative analysis of generic imatinib and glivec
AE Eskazan, S Sadri, D Keskin, M Ayer, B Kantarcioglu, N Demirel, ...
Clinical Lymphoma Myeloma and Leukemia 17 (12), 804-811, 2017
282017
Severe bone marrow failure due to valganciclovir overdose after renal transplantation from cadaveric donors: four consecutive cases
MC Ar, M Ozbalak, N Tuzuner, H Bekoz, O Ozer, K Ugurlu, F Tabak, ...
Transplantation proceedings 41 (5), 1648-1653, 2009
282009
The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia
AE Eskazan, T Elverdi, FF Yalniz, A Salihoglu, MC Ar, S Ongoren Aydin, ...
Leukemia & Lymphoma 55 (12), 2935-2937, 2014
272014
Generics in chronic myeloid leukemia: current arguments for and against and the established evidence
T Soysal, AE Eskazan, MC Ar
Expert Review of Hematology 7 (6), 697-699, 2014
252014
How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review
U Yilmaz, MC Ar, SN Esatoglu, I Bavunoglu, YZ Erzin, AI Hatemi, ...
Annals of hematology 99, 1193-1203, 2020
242020
Secondary infections in febrile neutropenia in hematological malignancies: more than another febrile neutropenic episode
A Demirel, F Tabak, MC Ar, B Mete, Ş Öngören, M Yemişen, R Özaras, ...
Turkish Journal of Hematology 32 (3), 243, 2015
242015
Intracranial extramedullary hematopoiesis in patients with thalassemia: a case report and review of the literature
AE Eskazan, MC Ar, Z Baslar
Transfusion 52 (8), 1715-1720, 2012
242012
An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality
R Kara Ali, S Surme, II Balkan, A Salihoglu, M Sahin Ozdemir, Y Ozdemir, ...
Annals of hematology 99, 1925-1932, 2020
232020
Personalized prophylaxis in people with hemophilia A: challenges and achievements
MC Ar, Z Baslar, T Soysal
Expert Review of Hematology 9 (12), 1203-1208, 2016
232016
Polycythemia vera: diagnosis, clinical course, and current management
Y Büyükaşik, R Ali, MC Ar, M Turgut, AS YAVUZ, G Saydam
Turkish journal of medical sciences 48 (4), 698-710, 2018
222018
Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis
G Cetin, T Ozkan, S Turgut, M Ali Cikrikcioglu, M Cem Ar, M Ayer, A Unlu, ...
Molecular biology reports 41, 6737-6742, 2014
222014
Portal hypertension and myeloproliferative neoplasms: a relationship revealed
AB Toros, S Gokcay, G Cetin, MC Ar, Y Karagoz, B Kesici
International Scholarly Research Notices 2013, 2013
222013
The system can't perform the operation now. Try again later.
Articles 1–20